Maria Julia Gregorio Calas

Maria Julia Gregorio Calas

Auto-generated profile, based on publicly available information

Maria Julia Gregorio Calas

Universidade Estácio de Sá, Brazil

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in Radiologia Brasileira
Verified
Journal Article
Open access
PDF file
GCGracy de Almeida Coutinho Carneiro
Gracy de Almeida Coutinho Carneiro
FPFernanda Philadelpho Arantes Pereira
Fernanda Philadelpho Arantes Pereira
FLFlavia Paiva Proença Lobo Lopes
Flavia Paiva Proença Lobo Lopes
MCMaria Julia Gregorio Calas
Maria Julia Gregorio Calas
Objective: To demonstrate the frequency of malignancy and histological characteristics of lesions in patients submitted to vacuum-assisted breast biopsy guided by magnetic resonance imaging (MRI). Materials and Methods: This was a retrospective study of MRI-guided vacuum-assisted breast biopsies performed between April 2008 and December 2016, in which we analyzed clinical and epidemiological data, as well as the BI-RADS classification and histopathological results. We compared nodules and non-nodular enhancements, in terms of their correlation with malignancy, using chi-square test. Results: Among 215 cases referred for MRI-guided vacuum-assisted breast biopsy, the procedure was contraindicated in 10 cases (5%) and was technically feasible in the remaining 205 (95%). Non-nodular enhancements were observed in 135 cases (66%), and nodules were observed in 70 (34%), with a mean diameter of 2.2 cm (range, 0.5-9.6 cm) and 0.97 cm (range, 0.5-2.2 cm), respectively. Of the 205 lesions analyzed, 43 (21%) were malignant, 129 (63%) were benign, and 33 (16%) were classified as high-risk lesions. The most common histological findings were invasive ductal carcinoma and, in high-risk cases, lobular neoplasia. There was no significant difference between nodules and non-nodular enhancements in terms of the rate of malignancy (p = 0.725). Conclusion: In our sample, the overall malignancy rate was 21%. However, to improve the assessment of these results, it is necessary to correlate them with the surgical data and with data from the follow-up of benign cases.

1 October 2020 in Radiologia Brasileira
Verified
Journal Article
Open access
PDF file
MCMaria Julia Gregório Calas
Maria Julia Gregório Calas
FPFernanda Philadelpho Arantes Pereira
Fernanda Philadelpho Arantes Pereira
LGLeticia Pereira Gonçalves
Leticia Pereira Gonçalves
FLFlavia Paiva Proença Lobo Lopes
Flavia Paiva Proença Lobo Lopes
Objective: To evaluate the main technical limitations of automated breast ultrasound and to determine the proportion of examinations excluded. Materials and Methods: We evaluated 440 automated breast ultrasound examinations performed, over a 12-month period, by technicians using an established protocol. Results: In five cases (1.1%), the examination was deemed unacceptable for diagnostic purposes, those examinations therefore being excluded. Conclusion: Automated breast ultrasound is expected to overcome some of the major limitations of conventional ultrasound in breast cancer screening. In Brazil, this new method can be accepted for inclusion in routine clinical practice only after its advantages have been validated in the national context.

1 January 2022 in Mastology
Verified
Journal Article
Open access
MCMaria Julia Gregorio Calas
Maria Julia Gregorio Calas
RDRebeca Fernandes de Azevedo Dantas
Rebeca Fernandes de Azevedo Dantas
CCCarolina Bantim Ciscotto
Carolina Bantim Ciscotto
BGBruna Galper
Bruna Galper
ICIngrid Meira Lopes de Carvalho
Ingrid Meira Lopes de Carvalho
JGJuliana Moreira Guerra
Juliana Moreira Guerra
The lack of formal breast cancer screening guidelines for the transgender population and the unpreparedness of health professionals to provide adequate health care to this population are described in the literature. The objective of this integrative review was to present the proposals for breast cancer screening in the transgender population, based on the literature, being searched in the Medline, PubMed, SciELO, and Lilacs databases. The articles that addressed breast cancer screening in the female and/or male transgender population were selected, in addition to the associated studies with the use of hormone therapy and breast cancer in transgender people, using the terms such as “transgender people,” “early cancer diagnosis,” and “breast.” Of the 38 articles selected, 24 address recommendations for breast cancer screening in the female and/or male transgender population. There is limited population-based information on mammography screening in transgender people, which ultimately affects the analysis of cancer incidence in this population. The literature supports screening in the male transgender profile (similar to the female cisgender). In transgender females, recommendations are implemented based on expert’s opinions, such as mammographic screening after 5 years of hormone use. More studies on this subject are needed.

1 January 2019 in Mastology
Verified
Journal Article
Open access
LGLeticia Pereira Gonçalves
Leticia Pereira Gonçalves
CIClínica de Diagnóstico Por Imagem
Clínica de Diagnóstico Por Imagem
MLMariana Loureiro Lemos
Mariana Loureiro Lemos
MCMaria Julia Gregorio Calas
Maria Julia Gregorio Calas
Introduction: Breast Imaging Reporting and Data System (BI-RADS) classification allows standardization of breast masses findings, with a recommendation for individualized management. Because of their high frequency, masses classified as 3, probably benign, arouse interest in improving their characterization and in establishing the most appropriate behavior. Objective: Firstly, to demonstrate the positive and negative predictive values of the BI-RADS 3 classification of solid masses submitted to percutaneous biopsy by ultrasonography. Secondly, to suggest a different ultrasound follow-up conduct in these findings. Methods: We retrospectively studied 480 BI-RADS 3 masses, submitted to a biopsy under vacuum or core biopsy, with a conclusive histopathological result considered the gold standard. Results: From 480 masses in 396 patients, 473 were benign and 7 malignant. The positive predictive value for malignancy of category 3 masses was 1.5% (7/480), and the negative predictive value was 98.5%. Conclusion: In view of the low probability of cancer, it is recommended the performance of directed ultrasonography (second look) of masses classified as BI-RADS 3 performed by a specialist in breast radiology before the indication of an invasive procedure, what would substantially reduce the number of unnecessary biopsies, patient’s anxiety, as well as costs and possible related complications. This will increase the possibility for the specialist to spend more time on really necessary and targeted examinations, better defining cases of follow-up (annual or biannual) of the indication of investigation in specific cases.